Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
- PMID: 36432410
- PMCID: PMC9697729
- DOI: 10.3390/nu14224723
Prospects of Probiotic Adjuvant Drugs in Clinical Treatment
Abstract
In modern society, where new diseases and viruses are constantly emerging, drugs are still the most important means of resistance. However, adverse effects and diminished efficacy remain the leading cause of treatment failure and a major determinant of impaired health-related quality of life for patients. Clinical studies have shown that the disturbance of the gut microbial structure plays a crucial role in the toxic and side effects of drugs. It is well known that probiotics have the ability to maintain the balance of intestinal microecology, which implies their potential as an adjunct to prevent and alleviate the adverse reactions of drugs and to make medicines play a better role. In addition, in the past decade, probiotics have been found to have excellent prevention and alleviation effects in drug toxicity side effects, such as liver injury. In this review, we summarize the development history of probiotics, discuss the impact on drug side effects of probiotics, and propose the underlying mechanisms. Probiotics will be a new star in the world of complementary medicine.
Keywords: complementary medicine; drug side effects; intestinal flora; probiotics.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
[Probiotics' Ameliorating Effect on Side Effects of Cancer Treatment: Reflections and Prospects].Sichuan Da Xue Xue Bao Yi Xue Ban. 2022 May;53(3):532-537. doi: 10.12182/20220560508. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 35642167 Free PMC article. Review. Chinese.
-
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.Cochrane Database Syst Rev. 2019 Apr 30;4(4):CD004827. doi: 10.1002/14651858.CD004827.pub5. Cochrane Database Syst Rev. 2019. PMID: 31039287 Free PMC article.
-
Probiotics as modulators of the gut flora.Br J Nutr. 2002 Sep;88 Suppl 1:S39-49. doi: 10.1079/BJN2002628. Br J Nutr. 2002. PMID: 12215180 Review.
-
The potential role of prebiotics, probiotics, and synbiotics in adjuvant cancer therapy especially colorectal cancer.J Food Biochem. 2022 Oct;46(10):e14302. doi: 10.1111/jfbc.14302. Epub 2022 Jul 11. J Food Biochem. 2022. PMID: 35816322 Review.
-
Role of Probiotics in Human Gut Microbiome-Associated Diseases.J Microbiol Biotechnol. 2019 Sep 28;29(9):1335-1340. doi: 10.4014/jmb.1906.06064. J Microbiol Biotechnol. 2019. PMID: 31434172 Review.
Cited by
-
Exploring the role of inflammatory regulatory effects of probiotics as adjuvants in cancer development management with considering possible challenges: a comprehensive review.Inflammopharmacology. 2025 Jul;33(7):3823-3841. doi: 10.1007/s10787-025-01855-2. Epub 2025 Jul 16. Inflammopharmacology. 2025. PMID: 40670830 Review.
-
Journey of the Probiotic Bacteria: Survival of the Fittest.Microorganisms. 2022 Dec 30;11(1):95. doi: 10.3390/microorganisms11010095. Microorganisms. 2022. PMID: 36677387 Free PMC article. Review.
-
Faecal microbiota transplantation for eradicating Helicobacter pylori infection: clinical practice and theoretical postulation.eGastroenterology. 2024 Dec 23;2(4):e100099. doi: 10.1136/egastro-2024-100099. eCollection 2024 Oct. eGastroenterology. 2024. PMID: 39944265 Free PMC article. Review.
-
Advancements in the impact of human microbiota and probiotics on leukemia.Front Microbiol. 2024 Jul 3;15:1423838. doi: 10.3389/fmicb.2024.1423838. eCollection 2024. Front Microbiol. 2024. PMID: 39021626 Free PMC article. Review.
-
Gut Akkermansia enhances liver protection and facilitates copper removal during D-penicillamine treatment in a Wilson's disease model.Microbiol Spectr. 2025 Mar 31;13(5):e0057324. doi: 10.1128/spectrum.00573-24. Online ahead of print. Microbiol Spectr. 2025. PMID: 40162768 Free PMC article.
References
-
- Kanwal Z.G., Fatima N., Azhar S., Chohan O., Jabeen M., Yameen M.A. Implications of self-medication among medical students—A dilemma. J. Pak. Med. Assoc. 2018;68:1363–1367. - PubMed
-
- Imhann F., Vich Vila A., Bonder M.J., Lopez Manosalva A.G., Koonen D.P., Fu J., Wijmenga C., Zhernakova A., Weersma R.K. The influence of proton pump inhibitors and other commonly used medication on the gut microbiota. Gut Microbes. 2017;8:351–358. doi: 10.1080/19490976.2017.1284732. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous